Clinical factors affecting therapeutic response of conventional chemotherapy with bevacizumab in metastatic colon cancer

Authors :: Muhammad G. Kibriya
Mahbubur Rahman
TramAnh Xuan Phan
Rezwan Islam
Po-Huang Chyou
Source :: Journal of Clinical Oncology. 34:e15001-e15001
Publication Year :: 2016
Publisher :: American Society of Clinical Oncology (ASCO), 2016.
Abstract: e15001Background: Molecularly targeted agent like Bevacizumab (BZ) combining with conventional chemotherapy (CC) showed good clinical outcomes in patients with metastatic colorectal cancer (mCRC). ...

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Bevacizumab
Colorectal cancer
business.industry
medicine.disease
digestive system diseases
Internal medicine
medicine
Conventional chemotherapy
In patient
business
Metastatic colon cancer
medicine.drug

Full Text Access

Tools